These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2865275)

  • 21. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
    Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364.
    Saletu B; Grünberger J; Cepko H
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):421-37. PubMed ID: 2888736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physostigmine reversal of midazolam-induced electroencephalographic changes in healthy subjects.
    Ebert U; Oertel R; Kirch W
    Clin Pharmacol Ther; 2000 May; 67(5):538-48. PubMed ID: 10824633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemodynamic effects of the benzodiazepine antagonist flumazenil following laparotomy under total intravenous anesthesia using midazolam].
    Crozier TA; Sydow M; Müller J; Langenbeck M; Radke J; Kettler D
    Anaesthesist; 1989 Apr; 38(4):193-9. PubMed ID: 2499212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    van Gerven JM; Roncari G; Schoemaker RC; Massarella J; Keesmaat P; Kooyman H; Heizmann P; Zell M; Cohen AF; Dingemanse J
    Br J Clin Pharmacol; 1997 Nov; 44(5):487-93. PubMed ID: 9384466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
    Mandema JW; Kuck MT; Danhof M
    J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Postoperative reversal of loss of vigilance following midazolam with the use of the antagonist flumazenil (Ro 15-1788). A comparative study with a placebo and the use of EEG-power spectra].
    Freye E; Fournell A
    Anaesthesist; 1988 Mar; 37(3):162-6. PubMed ID: 3132866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788.
    Klotz U; Duka T; Dorow R; Doenicke A
    Br J Clin Pharmacol; 1985 Jan; 19(1):95-8. PubMed ID: 3919752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Beta activation following the intravenous administration of benzodiazepines and the specific antagonist flumazenil (Ro 15-1788)].
    Suttmann H; Rampf U; Juhl G; Greim M; Doenicke A
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1990 Mar; 21(1):20-8. PubMed ID: 1970957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Midazolam-induced increase in NaCl solution ingestion: differential effect of the benzodiazepine antagonists Ro 15-1788 and CGS 8216.
    Falk JL; Tang M
    Pharmacol Biochem Behav; 1984 Dec; 21(6):965-8. PubMed ID: 6441170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo.
    Malizia AL; Gunn RN; Wilson SJ; Waters SH; Bloomfield PM; Cunningham VJ; Nutt DJ
    Neuropharmacology; 1996; 35(9-10):1483-91. PubMed ID: 9014164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzodiazepine antagonism does not provoke a stress response.
    White PF; Shafer A; Boyle WA; Doze VA; Duncan S
    Anesthesiology; 1989 Apr; 70(4):636-9. PubMed ID: 2564753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semilinear canonical correlation applied to the measurement of the electroencephalographic effects of midazolam and flumazenil reversal.
    Schnider TW; Minto CF; Fiset P; Gregg KM; Shafer SL
    Anesthesiology; 1996 Mar; 84(3):510-9. PubMed ID: 8659777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of effect of nitrendipine on the pharmacokinetics and pharmacodynamics of midazolam during steady state.
    Handel J; Ziegler G; Gemeinhardt A; Stuber H; Fischer C; Klotz U
    Br J Clin Pharmacol; 1988 Feb; 25(2):243-50. PubMed ID: 3358886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of the effects of midazolam on phrenic nerve activity in the dog by Ro 15-1788 and Ro 15-3505.
    Gordon G; Grundy EM; Al-Khudhairi D; Anderson DJ; Whitwam JG
    Br J Anaesth; 1984 Oct; 56(10):1161-5. PubMed ID: 6433950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation.
    Schöpf J; Laurian S; Le PK; Gaillard JM
    Pharmacopsychiatry; 1984 May; 17(3):79-83. PubMed ID: 6429677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects.
    Hotz MA; Ritz R; Linder L; Scollo-Lavizzari G; Haefeli WE
    Br J Clin Pharmacol; 2000 Jan; 49(1):72-9. PubMed ID: 10606840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neurophysiological monitoring (electroencephalogram, evoked potentials) and the effects of benzodiazepines].
    Kochs E; Schulte am Esch J
    Anasth Intensivther Notfallmed; 1988 Jun; 23(3):145-52. PubMed ID: 2899984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam.
    Klotz U; Arvela P; Rosenkranz B
    Clin Pharmacol Ther; 1985 Dec; 38(6):652-5. PubMed ID: 2933205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.